Current views on type 2 diabetes.

Type 2 diabetes mellitus (T2DM) affects a large population worldwide. T2DM is a complex heterogeneous group of metabolic disorders including hyperglycemia and impaired insulin action and/or insulin secretion. T2DM causes dysfunctions in multiple organs or tissues. Current theories of T2DM include a defect in insulin-mediated glucose uptake in muscle, a dysfunction of the pancreatic beta-cells, a disruption of secretory function of adipocytes, and an impaired insulin action in liver. The etiology of human T2DM is multifactorial, with genetic background and physical inactivity as two critical components. The pathogenesis of T2DM is not fully understood. Animal models of T2DM have been proved to be useful to study the pathogenesis of, and to find a new therapy for, the disease. Although different animal models share similar characteristics, each mimics a specific aspect of genetic, endocrine, metabolic, and morphologic changes that occur in human T2DM. The purpose of this review is to provide the recent progress and current theories in T2DM and to summarize animal models for studying the pathogenesis of the disease.

[1]  Asker E Jeukendrup,et al.  Physical inactivity and obesity: links with insulin resistance and type 2 diabetes mellitus , 2009, Diabetes/metabolism research and reviews.

[2]  D. Leroith,et al.  A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. , 2009, The Journal of biological chemistry.

[3]  R. Seeley,et al.  Targeting the CNS to treat type 2 diabetes , 2009, Nature Reviews Drug Discovery.

[4]  J. Florez,et al.  Clinical translation of genetic predictors for type 2 diabetes , 2009, Current opinion in endocrinology, diabetes, and obesity.

[5]  Leif Groop,et al.  Genetic dissection of type 2 diabetes , 2009, Molecular and Cellular Endocrinology.

[6]  S. Mcphee,et al.  Current Medical Diagnosis and Treatment , 2009, Journal of Nuclear Medicine.

[7]  V. Randhawa,et al.  Insulin action on glucose transporters through molecular switches, tracks and tethers. , 2008, The Biochemical journal.

[8]  H. Häring,et al.  How insulin receptor substrate proteins regulate the metabolic capacity of the liver--implications for health and disease. , 2008, Current medicinal chemistry.

[9]  M. Cuttle,et al.  Insulin-triggered repositioning of munc18c on syntaxin-4 in GLUT4 signalling. , 2008, The Biochemical journal.

[10]  M. White,et al.  Insulin-like signaling, nutrient homeostasis, and life span. , 2008, Annual review of physiology.

[11]  T. Asano,et al.  Role of phosphatidylinositol 3-kinase activation on insulin action and its alteration in diabetic conditions. , 2007, Biological & pharmaceutical bulletin.

[12]  P. Ramarao,et al.  Animal models in type 2 diabetes research: an overview. , 2007, The Indian journal of medical research.

[13]  M. Lawrence,et al.  The insulin and EGF receptor structures: new insights into ligand-induced receptor activation. , 2007, Trends in biochemical sciences.

[14]  R. Wolfe,et al.  Contraction of insulin-resistant muscle normalizes insulin action in association with increased mitochondrial activity and fatty acid catabolism. , 2007, American journal of physiology. Cell physiology.

[15]  S. Kahn,et al.  Mechanisms linking obesity to insulin resistance and type 2 diabetes , 2006, Nature.

[16]  D. James,et al.  Molecular Dissection of the Munc18c/Syntaxin4 Interaction: Implications for Regulation of Membrane Trafficking , 2006, Traffic.

[17]  M. Lawrence,et al.  Structure of the insulin receptor ectodomain reveals a folded-over conformation , 2006, Nature.

[18]  Reinhard Jahn,et al.  SNAREs — engines for membrane fusion , 2006, Nature Reviews Molecular Cell Biology.

[19]  S. Elbein,et al.  The Genetic Basis of Type 2 Diabetes. , 2006, Cellscience.

[20]  E. Lander,et al.  Reactive oxygen species have a causal role in multiple forms of insulin resistance , 2006, Nature.

[21]  G. Truett,et al.  Development of insulin resistance and hyperphagia in Zucker fatty rats. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[22]  C. Knauf,et al.  Liver-specific deletion of insulin receptor substrate 2 does not impair hepatic glucose and lipid metabolism in mice , 2006, Diabetologia.

[23]  Xueying Lin,et al.  Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth. , 2006, The Journal of clinical investigation.

[24]  K. Petersen,et al.  Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. , 2005, The Journal of clinical investigation.

[25]  H. Kaneto,et al.  Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic β-cell dysfunction and insulin resistance , 2005 .

[26]  Nimesh Mody,et al.  Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes , 2005, Nature.

[27]  R. DeFronzo,et al.  Dose-response effect of elevated plasma free fatty acid on insulin signaling. , 2005, Diabetes.

[28]  K. Petersen,et al.  Mitochondrial dysfunction and type 2 diabetes , 2005, Current diabetes reports.

[29]  K. Wellen,et al.  Inflammation, stress, and diabetes. , 2005, The Journal of clinical investigation.

[30]  G. Lutty,et al.  Neutrophils are associated with capillary closure in spontaneously diabetic monkey retinas. , 2005, Diabetes.

[31]  Michael Stumvoll,et al.  Type 2 diabetes: principles of pathogenesis and therapy , 2005, The Lancet.

[32]  R. Gimeno,et al.  Adipose tissue as an active endocrine organ: recent advances. , 2005, Current opinion in pharmacology.

[33]  J. Zierath,et al.  Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes. , 2005, Biochemical Society transactions.

[34]  C. Taniguchi,et al.  Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. , 2005, The Journal of clinical investigation.

[35]  P. Iyengar,et al.  The Hyperglycemia-induced Inflammatory Response in Adipocytes , 2005, Journal of Biological Chemistry.

[36]  J. Miyazaki,et al.  Adipocytes from Munc18c-null mice show increased sensitivity to insulin-stimulated GLUT4 externalization. , 2005, The Journal of clinical investigation.

[37]  M. Lazar,et al.  How Obesity Causes Diabetes: Not a Tall Tale , 2005, Science.

[38]  Christopher J. Rhodes,et al.  Type 2 Diabetes-a Matter of ß-Cell Life and Death? , 2005, Science.

[39]  Morihiro Matsuda,et al.  Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.

[40]  Xueying Lin,et al.  Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. , 2004, The Journal of clinical investigation.

[41]  J. Manson,et al.  Relationship of physical activity vs body mass index with type 2 diabetes in women. , 2004, JAMA.

[42]  S. Shoelson,et al.  Insulin Resistance Due to Phosphorylation of Insulin Receptor Substrate-1 at Serine 302* , 2004, Journal of Biological Chemistry.

[43]  D. Accili Lilly lecture 2003: the struggle for mastery in insulin action: from triumvirate to republic. , 2004, Diabetes.

[44]  R. Mooney,et al.  Hepatocytes: critical for glucose homeostasis. , 2004, The international journal of biochemistry & cell biology.

[45]  K. Petersen,et al.  Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. , 2004, The New England journal of medicine.

[46]  P. Halban,et al.  Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications , 2004, Diabetologia.

[47]  M. White Insulin Signaling in Health and Disease , 2003, Science.

[48]  Sunmin Park,et al.  Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes. , 2003, The Journal of clinical investigation.

[49]  E. Gabazza,et al.  Oxidative stress is associated with adiposity and insulin resistance in men. , 2003, The Journal of clinical endocrinology and metabolism.

[50]  C. Kahn,et al.  Tissue-specific Ablation of the GLUT4 Glucose Transporter or the Insulin Receptor Challenges Assumptions about Insulin Action and Glucose Homeostasis* , 2003, Journal of Biological Chemistry.

[51]  Kathrin Maedler,et al.  Inflammatory mediators and islet β-cell failure: a link between type 1 and type 2 diabetes , 2003, Journal of Molecular Medicine.

[52]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[53]  A. Butte,et al.  Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Kumar Sharma,et al.  Diabetic kidney disease in the db/db mouse. , 2003, American journal of physiology. Renal physiology.

[55]  A. Belfiore,et al.  Signaling differences from the A and B isoforms of the insulin receptor (IR) in 32D cells in the presence or absence of IR substrate-1. , 2003, Endocrinology.

[56]  C. Kahn,et al.  Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production. , 2003, The Journal of clinical investigation.

[57]  S. Kahn,et al.  The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes , 2003, Diabetologia.

[58]  G. Shulman,et al.  Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle* , 2002, The Journal of Biological Chemistry.

[59]  D. Ron,et al.  Endoplasmic reticulum stress and the development of diabetes: a review. , 2002, Diabetes.

[60]  N. Ruderman,et al.  Lipid-Induced Insulin Resistance in Human Muscle Is Associated With Changes in Diacylglycerol, Protein Kinase C, and IκB-α , 2002 .

[61]  C. Kahn,et al.  Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance , 2002, Clinical endocrinology.

[62]  H. Lodish,et al.  Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. , 2002, American journal of physiology. Endocrinology and metabolism.

[63]  A. Baudry,et al.  Genetic manipulation of insulin signaling, action and secretion in mice , 2002, EMBO reports.

[64]  Jiong Wu,et al.  Molecular Mechanism of Insulin-Induced Degradation of Insulin Receptor Substrate 1 , 2002, Molecular and Cellular Biology.

[65]  R. Robertson,et al.  Minireview: Secondary β-Cell Failure in Type 2 Diabetes-A Convergence of Glucotoxicity and Lipotoxicity. , 2002, Endocrinology.

[66]  M. White,et al.  Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action* , 2002, The Journal of Biological Chemistry.

[67]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[68]  D. Withers,et al.  Insulin receptor substrate proteins and neuroendocrine function. , 2001, Biochemical Society transactions.

[69]  G. Shulman,et al.  Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver , 2001, Nature.

[70]  W. Saris,et al.  Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise. , 2000, Diabetes.

[71]  J. Schlessinger,et al.  Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.

[72]  J. Schlessinger Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.

[73]  L. Foster,et al.  Mechanism and regulation of GLUT-4 vesicle fusion in muscle and fat cells. , 2000, American journal of physiology. Cell physiology.

[74]  J. Rothman,et al.  Compartmental specificity of cellular membrane fusion encoded in SNARE proteins , 2000, Nature.

[75]  D. Moller Potential Role of TNF-α in the Pathogenesis of Insulin Resistance and Type 2 Diabetes , 2000, Trends in Endocrinology & Metabolism.

[76]  C. Kahn,et al.  Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance , 2000, Nature Medicine.

[77]  J. Zierath,et al.  Insulin action and insulin resistance in human skeletal muscle , 2000, Diabetologia.

[78]  B. Wolffenbuttel,et al.  Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. , 2000, American journal of physiology. Endocrinology and metabolism.

[79]  C. Kahn,et al.  Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. , 2000, Molecular cell.

[80]  K. Yamasawa,et al.  Intraperitoneally implanted artificial pancrease with transkaryotic beta-cells on microcarrier beads in a diffusion chamber improves hyperglycemia after 90% pancreatectomy in rats. , 2000, In vivo.

[81]  L. Mandarino,et al.  Fuel selection in human skeletal muscle in insulin resistance: a reexamination. , 2000, Diabetes.

[82]  L. Gianaroli,et al.  ifferential expression and regulation of brain-derived neurotrophic factor BDNF ) mRNA isoforms in androgen-sensitive motoneurons of the rat lumbar pinal cord , 2010 .

[83]  M. Kasuga,et al.  Role of SNAP23 in Insulin-induced Translocation of GLUT4 in 3T3-L1 Adipocytes , 2000, The Journal of Biological Chemistry.

[84]  P. Ramarao,et al.  Insulin resistance: current therapeutic approaches. , 1999, Drugs of today.

[85]  E. Ziv,et al.  Nutritionally Induced Insulin Resistance and Receptor Defect Leading to β‐Cell Failure in Animal Models , 1999, Annals of the New York Academy of Sciences.

[86]  D. M. Rocha,et al.  Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. , 1999, Diabetes.

[87]  B. Kahn,et al.  Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus. , 1999, The New England journal of medicine.

[88]  G. Boden Free fatty acids, insulin resistance, and type 2 diabetes mellitus. , 1999, Proceedings of the Association of American Physicians.

[89]  B. Kennedy,et al.  Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. , 1999, Science.

[90]  C. Kahn,et al.  Tissue-Specific Knockout of the Insulin Receptor in Pancreatic β Cells Creates an Insulin Secretory Defect Similar to that in Type 2 Diabetes , 1999, Cell.

[91]  J. Pessin,et al.  Regulation of Insulin-stimulated GLUT4 Translocation by Munc18c in 3T3L1 Adipocytes* , 1998, The Journal of Biological Chemistry.

[92]  E. Ferrannini Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. , 1998, Endocrine reviews.

[93]  R. Farese,et al.  Evidence for Involvement of Protein Kinase C (PKC)-ζ and Noninvolvement of Diacylglycerol-Sensitive PKCs in Insulin-Stimulated Glucose Transport in L6 Myotubes. , 1997, Endocrinology.

[94]  R A Roth,et al.  Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612. , 1997, Biochemistry.

[95]  D. Accili,et al.  Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. , 1997, Developmental biology.

[96]  G. Dohm,et al.  Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. , 1997, The Journal of clinical investigation.

[97]  C. Mastick,et al.  Association of N-Ethylmaleimide Sensitive Fusion (NSF) Protein and Soluble NSF Attachment Proteins-α and -γ with Glucose Transporter-4-Containing Vesicles in Primary Rat Adipocytes. , 1997, Endocrinology.

[98]  R. Vigneri,et al.  Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-a gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity , 1997, Diabetologia.

[99]  J. Chernoff,et al.  Protein-Tyrosine Phosphatase 1B Complexes with the Insulin Receptor in Vivo and Is Tyrosine-phosphorylated in the Presence of Insulin* , 1997, The Journal of Biological Chemistry.

[100]  H. Beck-Nielsen,et al.  Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects , 1996, Diabetologia.

[101]  B. Spiegelman,et al.  IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.

[102]  William Arbuthnot Sir Lane,et al.  Role of IRS-2 in insulin and cytokine signalling , 1995, Nature.

[103]  S. Hubbard,et al.  Crystal structure of the tyrosine kinase domain of the human insulin receptor , 1994, Nature.

[104]  J. Simoneau,et al.  Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. , 1994, The Journal of clinical investigation.

[105]  C. Kahn,et al.  Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene , 1994, Nature.

[106]  C. Kahn,et al.  The insulin signaling system. , 1994, The Journal of biological chemistry.

[107]  M. Mueckler,et al.  Evidence from transgenic mice that glucose transport is rate-limiting for glycogen deposition and glycolysis in skeletal muscle. , 1993, The Journal of biological chemistry.

[108]  E. Shafrir,et al.  Animal models of non-insulin-dependent diabetes. , 1992, Diabetes/metabolism reviews.

[109]  R. DeFronzo,et al.  Pathogenesis of NIDDM: A Balanced Overview , 1992, Diabetes Care.

[110]  D. James,et al.  Differential regulation of two distinct glucose transporter species expressed in 3T3-L1 adipocytes: effect of chronic insulin and tolbutamide treatment. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[111]  R. Hye,et al.  Animal models of diabetes mellitus: physiology and pathology. , 1983, The Journal of surgical research.

[112]  N. Rakieten,et al.  Studies on the diabetogenic action of streptozotocin (NSC-37917). , 1963, Cancer chemotherapy reports.

[113]  K. Narayan,et al.  Clinical risk factors, DNA variants, and the development of type 2 diabetes. , 2009, The New England journal of medicine.

[114]  G. Ramadori,et al.  Carbohydrate metabolism and the liver: actual aspects from physiology and disease. , 2007, Zeitschrift fur Gastroenterologie.

[115]  J. Olefsky,et al.  Stressed out about obesity and insulin resistance , 2006, Nature Medicine.

[116]  W. Cefalu Animal models of type 2 diabetes: clinical presentation and pathophysiological relevance to the human condition. , 2006, ILAR journal.

[117]  H. Kaneto,et al.  Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic beta-cell dysfunction and insulin resistance. , 2006, The international journal of biochemistry & cell biology.

[118]  C. Rhodes Type 2 diabetes-a matter of beta-cell life and death? , 2005, Science.

[119]  N. Ruderman,et al.  Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. , 2002, Diabetes.

[120]  R. Robertson,et al.  Minireview: Secondary beta-cell failure in type 2 diabetes--a convergence of glucotoxicity and lipotoxicity. , 2002, Endocrinology.

[121]  C. Wollheim,et al.  Mitochondrial function in normal and diabetic beta-cells. , 2001, Nature.

[122]  D. Moller Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. , 2000, Trends in endocrinology and metabolism: TEM.

[123]  R. Farese,et al.  Evidence for involvement of protein kinase C (PKC)-zeta and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes. , 1997, Endocrinology.

[124]  C. Mastick,et al.  Association of N-ethylmaleimide sensitive fusion (NSF) protein and soluble NSF attachment proteins-alpha and -gamma with glucose transporter-4-containing vesicles in primary rat adipocytes. , 1997, Endocrinology.

[125]  Mark D. Johnson,et al.  Early neonatal death in mice homozygous for a null allele of the insulin receptor gene , 1996, Nature Genetics.

[126]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[127]  J. Schlessinger,et al.  Signaling by Receptor Tyrosine Kinases , 1993 .

[128]  S. Pirt Genetic manipulation , 1976, Nature.